Hans Martin Seidel - 11 Aug 2025 Form 4 Insider Report for Third Harmonic Bio, Inc. (THRD)

Role
Director
Signature
/s/ Natalie Holles, Attorney-in-Fact
Issuer symbol
THRD
Transactions as of
11 Aug 2025
Net transactions value
$0
Form type
4
Filing time
14 Aug 2025, 16:06:24 UTC
Previous filing
10 Jun 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Seidel Hans Martin Director C/O THIRD HARMONIC BIO, INC., 1700 MONTGOMERY STREET, SUITE 210, SAN FRANCISCO /s/ Natalie Holles, Attorney-in-Fact 14 Aug 2025 0001946001

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction THRD Common Stock Other -85,753 -100% 0 11 Aug 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction THRD Stock Option Other $0 -53,090 -100% $0.000000 0 11 Aug 2025 Common Stock 53,090 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction reported is a cancellation of shares of common stock in connection with the dissolution of the Issuer.
F2 The reporting person received a liquidation distribution of $5.35 per share of Common Stock from Issuer.
F3 Represents payment of the liquidation distribution of $5.35 per share less the exercise price of such options.